Abstract

Sexual dysfunction is a frequent side effect of selective serotonin reuptake inhibitors and serotonin–norepinephrine reuptake inhibitors. However, accompanying the alteration in testosterone levels is uncommon. We present the case of a patient with major depressive disorder, posttraumatic stress disorder, and panic disorder, whose symptoms were well- controlled with venlafaxine-extended release (150 mg/d). Because of low testosterone levels, the venlafaxine treatment was tapered off.